[HTML][HTML] Effectiveness and Safety of Intracavernosal IncobotulinumtoxinA (Xeomin®) 100 U as an Add-on Therapy to Standard Pharmacological Treatment for Difficult …
F Giuliano, P Denys, C Joussain - Toxins, 2022 - mdpi.com
Registered pharmacological treatments are insufficiently effective for erectile dysfunction
(ED) in around 30% of affected men. Intracavernosal injection (ICI) of ona-and …
(ED) in around 30% of affected men. Intracavernosal injection (ICI) of ona-and …
Intracavernosal onabotulinumtoxinA exerts a synergistic pro-erectile effect when combined with sildenafil in spontaneously hypertensive rats
F Giuliano, C Joussain, P Denys… - The journal of sexual …, 2022 - academic.oup.com
ABSTRACT Background Botulinum toxin A (BTX-A) has a variety of uses in medicine. Some
evidence suggests that intracavernosal (ic) BTX-A injection administered in addition to …
evidence suggests that intracavernosal (ic) BTX-A injection administered in addition to …